HBV Lamivudine Resistance among Hepatitis B and HIV Co-infected Patients Starting Lamivudine, Stavudine and Nevirapine in Kenya

Widespread use of lamivudine in antiretroviral therapy may lead to hepatitis B virus resistance in HIV-HBV co-infected patients from endemic settings where tenofovir is not readily available. We evaluated 389 Kenyan HIV-infected adults before and for 18 months after starting highly-active antiretrov...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Nina Kim, H., Scott, John, Cent, Anne, Cook, Linda, Ashley Morrow, Rhoda, Richardson, Barbra, Tapia, Kenneth, Jerome, Keith R., Lule, Godfrey, John-Stewart, Grace, Chung, Michael H.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2011
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3177102/
https://ncbi.nlm.nih.gov/pubmed/21914062
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2893.2011.01466.x
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge